## MCK: McKesson Corporation - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.00 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (29% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($798.76)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Todayâ€™s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26**
- Source: ts2.tech | 20251225T045932 | Somewhat-Bullish | Relevance: 100%
- This article provides an after-hours update for McKesson Corporation (NYSE: MCK) on December 24, 2025, detailing its flat close and slight after-hours dip on a holiday-shortened trading day. It covers key financial numbers, recent analyst insights from Zacks, Nasdaq/BNK Invest, and MarketBeat, and highlights upcoming catalysts like earnings on February 4, 2026, and the declared dividend, along with technical levels and Wall Street outlooks for investors to consider before the market reopens on December 26, 2025.

**2. Does McKesson Still Offer Value After Its Big 2025 Run and Cash Flow Outlook?**
- Source: Simply Wall Street | 20251224T040842 | Bullish | Relevance: 100%
- McKesson's stock has seen significant growth in 2025, raising questions about its current valuation. Despite a recent slight pullback, the company is viewed as critical infrastructure in US healthcare. A Discounted Cash Flow analysis suggests McKesson is undervalued by 41.0%, while its Price to Earnings ratio also indicates undervaluation when considering its specific growth outlook and risk profile.

**3. McKesson Corporation $MCK Shares Bought by Exchange Traded Concepts LLC**
- Source: MarketBeat | 20251226T091216 | Bullish | Relevance: 100%
- Exchange Traded Concepts LLC increased its stake in McKesson Corporation (NYSE: MCK) by 58.5% in the third quarter, bringing their total holdings to 3,856 shares valued at approximately $2.98 million. Several analysts have raised their price targets for MCK, resulting in an average target of $892.86 and a "Moderate Buy" consensus rating. McKesson also reported strong Q3 earnings, beating EPS expectations with $9.86 and announcing a quarterly dividend of $0.82 per share.

**4. Brookstone Capital Management Acquires 1,569 Shares of McKesson Corporation $MCK**
- Source: MarketBeat | 20251226T085131 | Bullish | Relevance: 100%
- Brookstone Capital Management increased its stake in McKesson Corporation (NYSE:MCK) by 15.6% in the third quarter, acquiring an additional 1,569 shares, bringing its total holdings to 11,634 shares valued at $8.99 million. The article also notes an insider sale by CAO Napoleon B. Rutledge Jr., who sold 329 shares, and highlights that McKesson beat EPS estimates with a 10.2% YoY revenue increase, leading analysts to maintain a "Moderate Buy" rating. Financial data, institutional ownership, and a recent dividend announcement are also discussed.

**5. Vontobel Holding Ltd. Has $22.86 Million Position in McKesson Corporation $MCK**
- Source: MarketBeat | 20251225T111723 | Bullish | Relevance: 100%
- Vontobel Holding Ltd. recently reduced its stake in McKesson Corporation (NYSE:MCK) by 24.4% in the third quarter, now holding 29,588 shares valued at approximately $22.86 million. Despite this, other major institutional investors like Vanguard and Geode Capital Management have increased their holdings, reflecting strong institutional interest, with 85.07% of the company's stock owned by institutional investors. McKesson also exceeded quarterly EPS expectations, and analysts maintain a "Moderate Buy" consensus with an average target price of $892.86, while the company declared an $0.82 quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $960 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.3%)
- Blackrock Inc.: 9.2% (+0.4%)
- State Street Corpora: 4.7% (+0.9%)
- JPMORGAN CHASE & CO: 4.5% (+16.0%)
- Massachusetts Financ: 3.2% (-1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +1.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 indicates undervaluation relative to growth. Balance sheet: $2.3B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $103.0B |
| Beta | 0.38 |
| 52W Range | $565.75 - $895.58 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 18.9 |
| Current P/E | 21.4 |
| YoY Growth | 13.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.6% to 0.1% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.07), confirming momentum. RSI neutral at 53. Volume at 29% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.09% (CS: 54) | Neutral |
| RSI_14 | 52.6 | Neutral |
| MACD Histogram | 1.07 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 1.126x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $828.40
- **Stop Loss:** $798.76 (3.6% risk)
- **Target:** $887.68 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 44
- **Position Value:** $36,449.60
- **Portfolio %:** 36.45%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-04 (Est: $9.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.05 | $9.86 | +8.9% |
| 2025Q2 | $8.15 | $8.26 | +1.4% |
| 2025Q1 | $9.83 | $10.12 | +3.0% |
| 2024Q4 | $7.99 | $8.03 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*